Robert Weiland
2016
In 2016, Robert Weiland earned a total compensation of $1.9M as Chief Commercial Officer at Pacira Pharmaceuticals.
Compensation breakdown
| Bonus | $86,000 |
|---|---|
| Option Awards | $1,470,114 |
| Salary | $270,385 |
| Other | $98,079 |
| Total | $1,924,578 |
Weiland received $1.5M in option awards, accounting for 76% of the total pay in 2016.
Weiland also received $86K in bonus, $270.4K in salary and $98.1K in other compensation.
Rankings
In 2016, Robert Weiland's compensation ranked 5,054th out of 14,075 executives tracked by ExecPay. In other words, Weiland earned more than 64.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,054 out of 14,075 | 64th |
Division Manufacturing | 1,803 out of 5,486 | 67th |
Major group Chemicals And Allied Products | 572 out of 1,900 | 70th |
Industry group Drugs | 428 out of 1,543 | 72nd |
Industry Pharmaceutical Preparations | 343 out of 1,173 | 71st |
Source: SEC filing on April 21, 2017.
Weiland's colleagues
We found five more compensation records of executives who worked with Robert Weiland at Pacira Pharmaceuticals in 2016.
2016
David Stack
Pacira Pharmaceuticals
Chief Executive Officer
2016
Charles Reinhart
Pacira Pharmaceuticals
Chief Financial Officer
2016
James Scibetta
Pacira Pharmaceuticals
Chief Financial Officer
2016
Scott Braunstein
Pacira Pharmaceuticals
Senior Vice President, Strategy and Corporate Development
2016
Kristen Williams
Pacira Pharmaceuticals